PharmaResources Hits Day Low of CNY 39.10 Amid Price Pressure

PharmaResources (Shanghai) Co., a small-cap player in the miscellaneous industry, experienced a notable decline today, with its stock price dropping by 7.56% on March 3, 2026. The stock reached an intraday low of CNY 39.10, reflecting a challenging trading session compared to the broader market, where the China Shanghai Composite index fell by only 1.26%. Over the past week, PharmaResources has seen a more significant downturn, with a 11.45% decrease, and a 19.21% drop over the past month. Despite these recent declines, the company has shown resilience over the past year, boasting a return of 10.75%, although this is below the China Shanghai Composite's performance of 22.49%. Financially, PharmaResources has reported impressive growth metrics, including a pre-tax profit increase of 1,301% and a net profit growth of 312.6% in the latest quarter. The company maintains a strong operating cash flow of CNY 71.52 million, contributing to its overall market position. With a market capitalization of CNY 3,475 million, PharmaResources continues to navigate a competitive landscape while facing recent stock price pressures.